The association of metabolic syndrome and COVID-19 deterioration
- 28 mai 2021
Vivre-Covid19 : +5500 patients en phase de suivi !
- 6 avr. 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated [...]
- 18 nov. 2020
CHU Lille | MentCovRMD | COVID-19 | e-cohorte
- 31 oct. 2020
Malnutrition: Percentage and Association with Prognosis in Patients Hospitalized for [...]
- 13 oct. 2020
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases [...]
- 29 sept. 2020
VIVRE-COVID19 - projet collaboratif pour une étude longitudinale observationnelle sur 10 000 [...]
- 11 juin 2020
GERPAL | COVIMID | COVID-19 | e-cohorte | Europe
- 27 mai 2020
CHU Dijon | PRO-COVID | COVID-19 | e-cohorte
- 14 mai 2020
France Assos Santé | Vivre-COVID19 | COVID-19 | e-cohorte
- 16 avr. 2020
FAI2R | RMD-cohort | COVID-19 | e-cohorte
- 15 avr. 2020
Cohorte FAI2R - COVID19
- 7 avr. 2020
AP-HP | MétaboNutriCovid | COVID-19 | e-cohorte
S.A.S.U fondée en 2010
capital social de 8 000 Euros
R.C.S. Marseille 528233190
188, av 2nd Division Blindée
13420 Gémenos – FRANCE
tel : +33 4 84 83 00 60